We are live on ! Find out more
EVFM

Evofem Biosciences, Inc. Common Stock
EVFM

Delisted

EVFM was delisted on the 10th of August, 2022.

Back to rankings

71 hedge funds and large institutions have $19.8M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more call options, than puts

Call options by funds: $2.04M | Put options by funds: $611K

12% less funds holding

Funds holding: 81 → 71 (-10)

32% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 19

45% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 20

52% less capital invested

Capital invested by funds: $40.8M → $19.8M (-$21M)

Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
19
Closed
20
Calls
$2.04M
Puts
$611K
Net Calls
+$1.43M
Net Calls Change
+$136K

Top Buyers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$905K
2
BlackRock
BlackRock
New York
+$396K
3
Bank of America
Bank of America
North Carolina
+$202K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$152K
5
SW
SteelPeak Wealth
California
+$50.3K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.3M
2
Millennium Management
Millennium Management
New York
-$2.53M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.7M
4
HA
Heartland Advisors
Wisconsin
-$1.24M
5
TWMP
Taylor Wealth Management Partners
Massachusetts
-$574K
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
76
Squarepoint
New York
– -$13K -751 Closed
Deutsche Bank
77
Deutsche Bank
Germany
– -$11K -643 Closed
CAPTRUST Financial Advisors
78
CAPTRUST Financial Advisors
North Carolina
– -$1K -84 Closed
Citigroup
79
Citigroup
New York
– -$1K -67 Closed
New York State Common Retirement Fund
80
New York State Common Retirement Fund
New York
– -$1K -46 Closed
1 2 3
4

EVFM Hedge Fund Activity: Q3 2021 in Review

71 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Evofem Biosciences, Inc. Common Stock (EVFM) for Q3 2021, worth a combined $19.8M — down 52% from $40.8M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of EVFM and 11 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 13 added.

The largest buyer was Fuller & Thaler Asset Management, opening a new position worth an estimated $905K. The largest seller was Morgan Stanley, cutting an estimated $3.3M.

  • 71 institutional investors held Evofem Biosciences, Inc. Common Stock (EVFM) as of Q3 2021, down from 81 in Q2 2021.
  • Funds reported $19.8M of Evofem Biosciences, Inc. Common Stock stock for Q3 2021, down 52% quarter-over-quarter.
  • 11 funds opened new Evofem Biosciences, Inc. Common Stock positions in Q3 2021 and 20 closed out, a net change of -9 holders.
  • The largest Evofem Biosciences, Inc. Common Stock buyer in Q3 2021 was Fuller & Thaler Asset Management, an estimated $905K added.
  • The largest Evofem Biosciences, Inc. Common Stock seller in Q3 2021 was Morgan Stanley, an estimated $3.3M sold.

Based on aggregated 13F filings for Q3 2021.